Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome
Aim. To assess the effects of taurine on the parameters of 24-hour blood pressure monitoring (BPM) in patients with metabolic syndrome (MS) and chronic heart failure (CHF). Material and methods. In total, 60 patients were examined (mean age 54,4±7,4 years). The control group (CG) received enalapril...
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2164 |
id |
doaj-6ddd312b568c412fa8a7a978e556b152 |
---|---|
record_format |
Article |
spelling |
doaj-6ddd312b568c412fa8a7a978e556b1522021-07-28T13:50:40Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01251970-01-019765701873Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndromeI. V. Kryuchkova0A. S. Adamchik1Kuban State Medical University. KrasnodarKuban State Medical University. KrasnodarAim. To assess the effects of taurine on the parameters of 24-hour blood pressure monitoring (BPM) in patients with metabolic syndrome (MS) and chronic heart failure (CHF). Material and methods. In total, 60 patients were examined (mean age 54,4±7,4 years). The control group (CG) received enalapril and indapamide. The main group (MG) was additionally administered taurine for 12 months. All participants underwent anthropometry, office BP measurement, 24-hour BPM, and lipid profile assessment at baseline and at the end of the study. Results. The treatment was associated with changes in circadian profiles of systolic and diastolic BP (SBP, DBP) in both groups, with greater positive dynamics in the MG. The number of the patients with а “dipper” BP curve increased. Mean BP levels were significantly reduced. In the MG, time index for mean 24-hour SBP and DBP significantly decreased, by 49,9% and 42,3%, respectively. Mean 24-hour, day-time and night-time variability of SBP and DBP was normalised in the MG. Conclusion. Adding a metabolic agent to the combined antihypertensive therapy facilitated effective correction of circadian BP disturbances.https://cardiovascular.elpub.ru/jour/article/view/2164metabolic syndromechronic heart failure24-hour blood pressure monitoringtaurine |
collection |
DOAJ |
language |
Russian |
format |
Article |
sources |
DOAJ |
author |
I. V. Kryuchkova A. S. Adamchik |
spellingShingle |
I. V. Kryuchkova A. S. Adamchik Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome Кардиоваскулярная терапия и профилактика metabolic syndrome chronic heart failure 24-hour blood pressure monitoring taurine |
author_facet |
I. V. Kryuchkova A. S. Adamchik |
author_sort |
I. V. Kryuchkova |
title |
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
title_short |
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
title_full |
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
title_fullStr |
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
title_full_unstemmed |
Taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
title_sort |
taurine effects on 24-hour blood pressure monitoring parameters in patients with chronic heart failure and metabolic syndrome |
publisher |
«SILICEA-POLIGRAF» LLC |
series |
Кардиоваскулярная терапия и профилактика |
issn |
1728-8800 2619-0125 |
publishDate |
1970-01-01 |
description |
Aim. To assess the effects of taurine on the parameters of 24-hour blood pressure monitoring (BPM) in patients with metabolic syndrome (MS) and chronic heart failure (CHF). Material and methods. In total, 60 patients were examined (mean age 54,4±7,4 years). The control group (CG) received enalapril and indapamide. The main group (MG) was additionally administered taurine for 12 months. All participants underwent anthropometry, office BP measurement, 24-hour BPM, and lipid profile assessment at baseline and at the end of the study. Results. The treatment was associated with changes in circadian profiles of systolic and diastolic BP (SBP, DBP) in both groups, with greater positive dynamics in the MG. The number of the patients with а “dipper” BP curve increased. Mean BP levels were significantly reduced. In the MG, time index for mean 24-hour SBP and DBP significantly decreased, by 49,9% and 42,3%, respectively. Mean 24-hour, day-time and night-time variability of SBP and DBP was normalised in the MG. Conclusion. Adding a metabolic agent to the combined antihypertensive therapy facilitated effective correction of circadian BP disturbances. |
topic |
metabolic syndrome chronic heart failure 24-hour blood pressure monitoring taurine |
url |
https://cardiovascular.elpub.ru/jour/article/view/2164 |
work_keys_str_mv |
AT ivkryuchkova taurineeffectson24hourbloodpressuremonitoringparametersinpatientswithchronicheartfailureandmetabolicsyndrome AT asadamchik taurineeffectson24hourbloodpressuremonitoringparametersinpatientswithchronicheartfailureandmetabolicsyndrome |
_version_ |
1721271459176775680 |